《業績》惠普(HPQ.US)上季盈利及預測均遜預期 盤後股價挫15%
惠普(HPQ.US)公布,第二季度調整後每股盈利為71美仙,低於預期的80美仙。營收按年增3%至132.2億美元,略高於預期的131.4億美元。
惠普稱為反映目前美國關稅帶來的額外成本,預計第三季調整後每股盈利為68美仙至80美仙,低於預期的90美仙。全年調整後收益將在每股盈利3美元至3.3美元之間,低於預期的3.49美元。
惠普執行長 Enrique Lores稱,已增加在越南、泰國、印度、墨西哥和美國的產量,至6月底公司預計在北美銷售所有產品將在中國以外生產。
該股周三盤後下挫15%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.